<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03210000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P00973</UniProt_ID>
  <Seq_Length>400</Seq_Length>
  <Molecule_Weight>46029</Molecule_Weight>
  <KEGG_ID>hsa:4938</KEGG_ID>
  <Orthology_ID>K14216</Orthology_ID>
  <Function_Summary>May play a role in mediating resistance to virus infection, control of cell growth, differentiation, and apoptosis.</Function_Summary>
  <Catalytic_Mechanism>Binds double-stranded RNA and polymerizes ATP into PPP(A2'P5'A)N oligomers, which activate the latent RNase L that, when activated, cleaves single-stranded RNAs.</Catalytic_Mechanism>
  <Pfam_ID>PF01909:NTP_transf_2@@PF10421:OAS1_C</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>2-5A synthetase 1</Alias>
      <Alias>2'-5'-oligoadenylate synthase 1</Alias>
      <Alias>2'-5' oligoadenylate synthetase 1 p52 isoform</Alias>
      <Alias>(2-5')oligo(A) synthetase 1</Alias>
      <Alias>2'-5'-oligoadenylate synthetase 1</Alias>
      <Alias>2'-5' oligoadenylate synthetase 1 p48 isoform</Alias>
      <Alias>2',5'-oligo A synthetase 1</Alias>
      <Alias>(2-5')oligo(A) synthase 1</Alias>
      <Alias>2',5'-oligoadenylate (2-5A) synthetase</Alias>
      <Alias>E18/E16</Alias>
      <Alias>2-5A synthase 1</Alias>
      <Alias>2'-5'-oligoisoadenylate synthetase 1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with double-stranded RNA.</Detail>
      <Keyword>Double-stranded RNA binding</Keyword>
      <Ontology_ID>GO:0003725</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP = pppA(2'p5'A)n oligomers. This reaction requires the binding of double-stranded RNA.</Detail>
      <Keyword>2'-5'-oligoadenylate synthetase activity</Keyword>
      <Ontology_ID>GO:0001730</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a nucleotidyl group to a reactant.</Detail>
      <Keyword>Nucleotidyltransferase activity</Keyword>
      <Ontology_ID>GO:0016779</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an RNA molecule or a portion thereof.</Detail>
      <Keyword>RNA binding</Keyword>
      <Ontology_ID>GO:0003723</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with zinc (Zn) ions.</Detail>
      <Keyword>Zinc ion binding</Keyword>
      <Ontology_ID>GO:0008270</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>162</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>361</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>354</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>352</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>31</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.</Detail>
      <Keyword>Protein oligomerization</Keyword>
      <Ontology_ID>GO:0051259</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-alpha stimulus. Interferon-alpha is a type I interferon.</Detail>
      <Keyword>Cellular response to interferon-alpha</Keyword>
      <Ontology_ID>GO:0035457</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the rate, frequency, or extent of ribonuclease activity, catalysis of the hydrolysis of phosphodiester bonds in chains of RNA.</Detail>
      <Keyword>Regulation of ribonuclease activity</Keyword>
      <Ontology_ID>GO:0060700</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication.</Detail>
      <Keyword>Negative regulation of viral genome replication</Keyword>
      <Ontology_ID>GO:0045071</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.</Detail>
      <Keyword>Purine nucleotide biosynthetic process</Keyword>
      <Ontology_ID>GO:0006164</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular events generated as a consequence of interferon-gamma binding to a cell surface receptor.</Detail>
      <Keyword>Interferon-gamma-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0060333</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.</Detail>
      <Keyword>Type I interferon-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0060337</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Reactions triggered in response to the presence of a virus that act to protect the cell or organism.</Detail>
      <Keyword>Defense response to virus</Keyword>
      <Ontology_ID>GO:0051607</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MMDLRNTPAKSLDKFIEDYLLPDTCFRMQINHAIDIICGFLKERCFRGSSYPVCVSKVVKGGSSGKGTTLRGRSDADLVVFLSPLTTFQDQLNRRGEFIQEIRRQLEACQRERAFSVKFEVQAPRWGNPRALSFVLSSLQLGEGVEFDVLPAFDALGQLTGGYKPNPQIYVKLIEECTDLQKEGEFSTCFTELQRDFLKQRPTKLKSLIRLVKHWYQNCKKKLGKLPPQYALELLTVYAWERGSMKTHFNTAQGFRTVLELVINYQQLCIYWTKYYDFKNPIIEKYLRRQLTKPRPVILDPADPTGNLGGGDPKGWRQLAQEAEAWLNYPCFKNWDGSPVSSWILLAESNSADDETDDPRRYQKYGYIGTHEYPHFSHRPSTLQAASTPQAEEDWTCTIL</Protein_Seq>
    <DNA_Seq>GGGGGAAGAGATAAAAGCAAACAGGTCTGGGAGGCAGTTCTGTTGCCACTCTCTCTCCTGTCAATGATGGATCTCAGAAATACCCCAGCCAAATCTCTGGACAAGTTCATTGAAGACTATCTCTTGCCAGACACGTGTTTCCGCATGCAAATCAACCATGCCATTGACATCATCTGTGGGTTCCTGAAGGAAAGGTGCTTCCGAGGTAGCTCCTACCCTGTGTGTGTGTCCAAGGTGGTAAAGGGTGGCTCCTCAGGCAAGGGCACCACCCTCAGAGGCCGATCTGACGCTGACCTGGTTGTCTTCCTCAGTCCTCTCACCACTTTTCAGGATCAGTTAAATCGCCGGGGAGAGTTCATCCAGGAAATTAGGAGACAGCTGGAAGCCTGTCAAAGAGAGAGAGCATTTTCCGTGAAGTTTGAGGTCCAGGCTCCACGCTGGGGCAACCCCCGTGCGCTCAGCTTCGTACTGAGTTCGCTCCAGCTCGGGGAGGGGGTGGAGTTCGATGTGCTGCCTGCCTTTGATGCCCTGGGTCAGTTGACTGGCAGCTATAAACCTAACCCCCAAATCTATGTCAAGCTCATCGAGGAGTGCACCGACCTGCAGAAAGAGGGCGAGTTCTCCACCTGCTTCACAGAACTACAGAGAGACTTCCTGAAGCAGCGCCCCACCAAGCTCAAGAGCCTCATCCGCCTAGTCAAGCACTGGTACCAAAATTGTAAGAAGAAGCTTGGGAAGCTGCCACCTCAGTATGCCCTGGAGCTCCTGACGGTCTATGCTTGGGAGCGAGGGAGCATGAAAACACATTTCAACACAGCCCAGGGATTTCGGACGGTCTTGGAATTAGTCATAAACTACCAGCAACTCTGCATCTACTGGACAAAGTATTATGACTTTAAAAACCCCATTATTGAAAAGTACCTGAGAAGGCAGCTCACGAAACCCAGGCCTGTGATCCTGGACCCGGCGGACCCTACAGGAAACTTGGGTGGTGGAGACCCAAAGGGTTGGAGGCAGCTGGCACAAGAGGCTGAGGCCTGGCTGAATTACCCATGCTTTAAGAATTGGGATGGGTCCCCAGTGAGCTCCTGGATTCTGCTGGTGAGACCTCCTGCTTCCTCCCTGCCATTCATCCCTGCCCCTCTCCATGAAGCTTGAGACATATAGCTGGAGACCATTCTTTCCAAAGAACTTACCTCTTGCCAAAGGCCATTTATATTCATATAGTGACAGGCTGTGCTCCATATTTTACAGTCATTTTGGTCACAATCGAGGGTTTCTGGAATTTTCACATCCCTTGTCCAGAATTCATTCCCCTAAGAGTAATAATAAATAATCTCTAACACC</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Microsome</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Mitochondria</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>OAS1</Gene_Name>
    <Gene_Alias>OIAS</Gene_Alias>
    <Gene_ID>4938</Gene_ID>
    <Genbank_ACCN>NM_001032409</Genbank_ACCN>
    <Protein_ACCN>NP_001027581</Protein_ACCN>
    <HGNC_ID>8086</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/4938</Gene_URL>
    <UCSC_ID>uc001tud.3</UCSC_ID>
    <EMBL_ID>ENSG00000089127</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Tick-Borne Encephalitis</Disease_Name>
      <Disease_Detail>Tick-Borne Encephalitis</Disease_Detail>
      <Disease_DB>TCK001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tick_borne_encephalitis?search=OAS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>West Nile Encephalitis</Disease_Name>
      <Disease_Detail>West Nile Encephalitis</Disease_Detail>
      <Disease_DB>WST004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/west_nile_encephalitis?search=OAS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Type 1 Diabetes Mellitus</Disease_Name>
      <Disease_Detail>Diabetes Mellitus</Disease_Detail>
      <Disease_DB>TYP008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/type_1_diabetes_mellitus?search=OAS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>West Nile Virus</Disease_Name>
      <Disease_Detail>West Nile Virus</Disease_Detail>
      <Disease_DB>WST005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/west_nile_virus?search=OAS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Viral Infectious Disease</Disease_Name>
      <Disease_Detail>Viral Infectious Disease</Disease_Detail>
      <Disease_DB>VRL011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/viral_infectious_disease?search=OAS1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Structural basis for cytosolic double-stranded RNA surveillance by human OAS1</PDB_Title>
      <PDB_ID>4IG8</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4IG8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1.</PubMed_Title>
      <Author>Donovan, J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:1652-1657</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23319625?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05164</Pathway_ID>
      <Pathway_Title>Influenza A</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05164</Pathway_ID>
      <Pathway_Title>Influenza A</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05160</Pathway_ID>
      <Pathway_Title>Hepatitis C</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05162</Pathway_ID>
      <Pathway_Title>Measles</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.7.-</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/7/</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00200001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>